Searched for
RADIOLIGAND THERAPY
Novartis India launches Pluvicto for prostate cancer treatmentNovartis India has launched Pluvicto, the nation's first approved radioligand therapy for eligible prostate cancer patients. This precision...- India needs to remain attractive for innovation-led investment: Judith Love, NovartisWith an eye on India's blossoming market, Novartis is set to launch pioneering therapies, including radioligand and gene therapies. The com...
- Avammune’s big bet: Why the future of cancer treatment may come in a pillAs global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...
- Novartis experimental actinium-based drug shows promise in prostate cancer treatment: StudyNovartis' new experimental actinium-based drug shows promise against prostate cancer. Early data on Sunday revealed anti-tumour activity, e...
- Novartis sharpening India strategy as a pure-play innovatorNovartis India country president and managing director Amitabh Dube said India is gradually moving beyond its traditional role as a clinica...
- Novartis to buy experimental breast cancer drug in up to $3 billion dealSwiss drugmaker Novartis is set to acquire a promising breast cancer drug candidate from US biotech firm Synnovation Therapeutics. The deal...
- Novartis bets big on India; looks to grow beyond cost arbitrage to high-value innovationNovartis is significantly expanding its biomedical research and drug development operations in India, positioning it as a key global hub ou...
- What is Pluvicto, who is Scott Adams and why he needs Donald Trump help for saving his life? Trump allies respond to appeal. Here's what happened and everyone saidWhat is Pluvicto, who is Scott Adams and why he needs Donald Trump help for saving his life. Dilbert creator Scott Adams has sought Donald ...
Load More